Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors.
Saved in:
| Title: | Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors. |
|---|---|
| Authors: | Coleman, Niamh1 (AUTHOR) niacoleman@stjames.ie, Stephen, Bettzy1 (AUTHOR), Fu, Siqing1 (AUTHOR), Karp, Daniel1 (AUTHOR), Subbiah, Vivek2 (AUTHOR), Ahnert, Jordi Rodon1 (AUTHOR), Piha‐Paul, Sarina A.1 (AUTHOR), Wright, John3 (AUTHOR), Fessahaye, Senait N.1 (AUTHOR), Ouyang, Fengying1 (AUTHOR), Yilmaz, Bulent1 (AUTHOR), Meric‐Bernstam, Funda1,4,5 (AUTHOR), Naing, Aung1 (AUTHOR) anaing@mdanderson.org |
| Source: | Cancer Medicine. Feb2024, Vol. 13 Issue 3, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.6877 |
